E-LIB Suche - Ergebnisse für: Sbarigia, U.

1

EE192 The Relationship between Systematic Lupus Erythematos..:

Levy, J. ; Alemao, E. ; Sbarigia, U...
Value in Health. 26 (2023) 6 - p. S94 , 2023

Link: https://doi.org/10.1016/..

2

PIN52 A MODEL to Explore Clinical Outcomes with High Hepati..:

Sbarigia, U. ; Hashim, M. ; Vincken, T...
Value in Health. 23 (2020) - p. S553 , 2020

Link: https://doi.org/10.1016/..

3

PIN1 A COMPARATIVE NETWORK META-ANALYSIS OF STANDARD OF CAR..:

Sbarigia, U. ; Vincken, T. ; Wigfield, P....
Value in Health. 23 (2020) - p. S168 , 2020

Link: https://doi.org/10.1016/..

4

PIN100 IMPACT OF CHRONIC HEPATITIS B VIRUS INFECTION ON HEA..:

Colwell, H.H. ; Mathias, S.D. ; Sylvester, S.V...
Value in Health. 22 (2019) - p. S211 , 2019

Link: https://doi.org/10.1016/..

5

PIN58 ARE PUBLISHED HEALTH ECONOMIC MODELS FOR CHRONIC HEPA..:

Wigfield, P. ; Sbarigia, U. ; Vincken, T...
Value in Health. 22 (2019) - p. S649 , 2019

Link: https://doi.org/10.1016/..

6

PIN145 PATIENT PREFERENCES TOWARDS DRUG TREATMENT OF CHRONI..:

Hardtstock, F. ; Kocaata, Z. ; Wilke, T...
Value in Health. 22 (2019) - p. S662 , 2019

Link: https://doi.org/10.1016/..

7

The nature and impact of stigma in patients with chronic he..:

Smith-Palmer, J. ; Pollock, R. ; Bonroy, K....
Journal of Hepatology. 68 (2018) - p. S185 , 2018

Link: https://doi.org/10.1016/..

8

PIN61 - COST-EFFECTIVENESS OF ONCE-DAILY DARUNAVIR CONTAINI..:

Tanova, N. ; Cawston, H. ; Tronczynski, K....
Value in Health. 21 (2018) - p. S231 , 2018

Link: https://doi.org/10.1016/..

9

Value of Expanding Hcv Treatment Capacity in Germany Throug..:

Sbarigia, U ; Wirth, D ; Van Nuys, K...
Value in Health. 19 (2016) 7 - p. A422 , 2016

Link: https://doi.org/10.1016/..

10

Assessing The Consequences Of Sustained Off-Therapy Hbsag L..:

Hashim, M ; Cerri, K ; Sbarigia, U.
Value in Health. 19 (2016) 7 - p. A413 , 2016

Link: https://doi.org/10.1016/..

11

Testing for Ns5a Resistance in Order to Optimize Antiviral ..:

Westerhout, KY ; Bouwmeester, W ; Duchesne, I...
Value in Health. 18 (2015) 7 - p. A589 , 2015

Link: https://doi.org/10.1016/..

12

Relative Efficacy of Simeprevir (Smv) Versus Telaprevir (Tp..:

Diels, J ; Thilakarathne, P ; Van Sanden, S..
Value in Health. 18 (2015) 3 - p. A230-A231 , 2015

Link: https://doi.org/10.1016/..

13

Impact of Simeprevir Versus Telaprevir Triple Therapy for C..:

Scott, J. ; Corbett, C. ; Gilles, L....
Value in Health. 17 (2014) 7 - p. A682 , 2014

Link: https://doi.org/10.1016/..

14

Mixed Treatment Comparisons to Compare Simeprevir with Boce..:

Taieb, V. ; Pacou, M. ; Van Sanden, S....
Value in Health. 17 (2014) 7 - p. A665 , 2014

Link: https://doi.org/10.1016/..

15

Predicting the Impact of Adverse Events and Treatment Durat..:

Akpo, H. ; Cerri, K. ; Sbarigia, U..
Value in Health. 17 (2014) 7 - p. A680-A681 , 2014

Link: https://doi.org/10.1016/..